The pre-seed round was led by DSW Ventures with participation from York Angels and international angel investors.
"We’re thrilled to have the backing of DSW Ventures, York Angels, and our wider investor group as we build the go-to platform for hybrid fitness athletes. This investment allows us to accelerate product development, enhance the user experience, and grow our footprint within the Hyrox and wider hybrid fitness communities. As athletes ourselves, we’ve built RoxFit to solve real problems we’ve experienced, and this funding brings us one step closer to helping thousands more to train smarter and race better."
The pre seed round was led by Activant Capital and saw backing from several fintech funds and industry executives.
"This isn’t about replacing the old with the new; it’s about intelligently integrating both. We’re not chasing crypto hype, we’re leveraging stablecoins to remove friction, accelerate settlement, and drive improved performance in real-world financial operations."
The pre-seed round was led by Early Game Ventures to support team growth and platform integrations.
"This round gives us the firepower to move fast, expand our world-class team, and partner with games that want the most fair and safe environment for players to enjoy,"
The oversubscribed round will support the AEC start-up as it rolls out its MVP for real estate investors.
"We are proud to welcome BTC d.d., Avto Krka, and Imari Holdings Ltd, as partners who believe in our bold vision (to become the most efficient platform for real estate investors) and have committed to bring strategic value to LynxCraft far beyond capital."
Zinc VC has led a pre-seed funding round in Native Labs to accelerate platform deployment and feature development.
"We are excited to be partnering with the Native Labs team as they build the critical infrastructure required to accelerate the development and delivery of cell therapies. Their platform is addressing one of the most challenging bottlenecks in the field, enabling more seamless, data-driven communication between developers and manufacturers. In a market that is growing rapidly, and with the potential to transform patient outcomes, Native Labs is not only solving a deeply complex technical challenge but unlocking a massive opportunity for impact across the entire cell and gene therapy ecosystem."
